GL1X · GenesisL1 explorer

MolNFT v1 · #133127 · protein

Pandda analysis group deposition -- crystal structure of SARS-cov-2 helicase in complex with Z1614545742

5RM8: “Pandda analysis group deposition -- crystal structure of SARS-cov-2 helicase in complex with Z1614545742”. X-ray diffraction, 3 ligands (GQJ, ZN, PO4), 11 pockets (best druggability 0.75). MolNFT v1 #133127 on GenesisL1: 3D…

PDB
5RM8
Type
protein
Length
1,157 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Helicase
EC
3.6.4.12, 3.6.4.13
UniProt
P0DTD1
Ligands
GQJ, ZN, PO4
Pockets
11 · best druggability 0.75

Structure

x-ray diffraction · 2 distinct chains · 30% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHelicase (EC 3.6.4.12, 3.6.4.13)protein57230% helix, 23% strandP0DTD1
BHelicase (EC 3.6.4.12, 3.6.4.13)protein58530% helix, 24% strandP0DTD1

Ligands and binding sites

  • GQJ · methyl (2~{S},4~{R})-1-(furan-2-ylcarbonyl)-4-oxidanyl-pyrrolidine-2-carboxylate · ligand · chains A
  • ZN · Zinc ion · metal · 6 copies · chains A, B
  • PO4 · Phosphate ion · ion · 4 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

11 pockets found on a 1 Å grid, 7 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14360.750.8446empty
22540.700.8535empty
34670.670.7961empty
43650.660.8046empty
51730.600.8327PO4

Interfaces

1 interface between chains.

  • A–B · 714 Ų buried · 4 hydrogen bonds · protein-protein

Compared structures

  • 5RM8 · PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.